PROPANC BIOPHARMA INC
CUSIP 74346N701
Propanc Biopharma Inc has 6 institutional holders in Filings Flow’s 13F database, together reporting 462.4K shares worth $48,694 as of Q1 2026. The largest reported holders are Ubs Group AG, Jane Street Group, LLC, and Two Sigma Securities, LLC.
Institutional Holders
6
Q1 2026
Reported Value
$48,694
Ticker
unmapped
private placement or foreign
Quarters Tracked
3
Ownership Trend
Institutional holders
Total reported value
Holders
··Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| UBS Group AG$666.3B AUM | 0.00% | $19,357 | 182.6K | Q1 2026 |
| JANE STREET GROUP, LLC$777.2B AUM | 0.00% | $15,180 | 143.2K | Q1 2026 |
| TWO SIGMA SECURITIES, LLC$861M AUM | 0.00% | $13,674 | 25.5K | Q4 2025OLDER |
| TWO SIGMA INVESTMENTS, LP$123.9B AUM | 0.00% | $8,724 | 16.3K | Q4 2025OLDER |
| Marex Group Ltd$15.8B AUM | 0.00% | $7,179 | 67.7K | Q1 2026 |
| Virtu Financial LLC$2.4B AUM | 0.00% | $4,000 | 40.7K | Q1 2026 |
| Sassicaia Capital Advisers LLC$89M AUM | 0.00% | $1,696 | 16.0K | Q1 2026 |
| XTX Topco Ltd$5.8B AUM | 0.00% | $1,282 | 12.1K | Q1 2026 |
| MORGAN STANLEY$1.66T AUM | 0.00% | $1 | 1 | Q4 2025OLDER |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.